Healing of rat femoral segmental defect with bone morphogenetic protein-2: A dose response study

Journal of Musculoskeletal Neuronal Interactions

Volumn 12, Issue 1, 2012, Pages 28-37

  Angle, S R ^a,b   Sena, K ^a   Sumner, D R ^a,b   Virkus, W W ^a   Virdi, A S ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b University of Illinois at Chicago   (United States)

Author keywords

Critical size defect; Fracture; Growth factors

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE REMODELING; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMORAL SEGMENTAL DEFECT; FEMUR FRACTURE; FRACTURE HEALING; HISTOLOGY; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; TRABECULAR BONE; TREATMENT OUTCOME;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMUR; FRACTURE HEALING; HUMANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA; X-RAY MICROTOMOGRAPHY;

EID: 84857818533     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Musculoskeletal Injuries. The Burden of Musculoskeletal Diseases in the United States. 2008. pp. 123-162.
2. Praemer A, Furner S, Rice DP. Musculoskeletal Conditions in the United States. Park Ridge, Illinois: American Academy of Orthopaedic Surgeons; 1992.
3. Arrington ED, Smith WJ, Chambers HG, Bucknell AL, Davino NA. Complications of Iliac Crest Bone Graft Harvesting. Clin Orthop Relat Res 1996;329(329):300-9.
4. Vaccaro AR, Chiba K, Heller JG, Patel TC, Thalgott JS, Truumees E, Fischgrund JS, Craig MR, Berta SC, Wang JC. Bone Grafting Alternatives in Spinal Surgery. Spine J 2002;2(3):206-15.
5. Norman-Taylor FH, Villar RN. Bone Allograft: a Cause for Concern? J Bone Joint Surg Br 1997;79(2):178-80.
6. Hangody L, Feczko P, Bartha L, Bodo G, Kish G. Mosaicplasty for the Treatment of Articular Defects of the Knee and Ankle. Clin Orthop Relat Res 2001;(391Suppl):S328-S336.
7. Roder C, Eggli S, Aebi M, Busato A. The Validity of Clinical Examination in the Diagnosis of Loosening of Components in Total Hip Arthroplasty. J Bone Joint Surg Br 2003;85(1):37-44.
8. Einhorn TA. Clinical Applications of Recombinant Human BMPs: Early Experience and Future Development. J Bone Joint Surg Am 2003;85-A Suppl 3:82-8.
9. Lieberman JR, Daluiski A, Einhorn TA. The Role of Growth Factors in the Repair of Bone. Biology and Clinical Applications. J Bone Joint Surg Am 2002;84-A(6):1032-44.
10. Bourque WT, Gross M, Hall BK. Expression of Four Growth Factors During Fracture Repair. Int J Dev Biol 1993;37(4):573-9.
11. Andrew JG, Hoyland JA, Freemont AJ, Marsh DR. Platelet-Derived Growth Factor Expression in Normally Healing Human Fractures. Bone 1995;16(4):455-60.
12. Bostrom MP. Expression of Bone Morphogenetic Proteins in Fracture Healing. Clin Orthop Relat Res 1998; (355 Suppl):S116-S123.
13. Schmidmaier G, Wildemann B, Bail H, Lucke M, Fuchs T, Stemberger A, Flyvbjerg A, Haas NP, Raschke M. Local Application of Growth Factors (Insulin-Like Growth Factor-1 and Transforming Growth Factor-Beta1) From a Biodegradable Poly(D,L-Lactide) Coating of Osteosynthetic Implants Accelerates Fracture Healing in Rats. Bone 2001;28(4):341-50.
14. Hollinger JO, Onikepe AO, MacKrell J, Einhorn T, Bradica G, Lynch S, Hart CE. Accelerated Fracture Healing in the Geriatric, Osteoporotic Rat With Recombinant Human Platelet-Derived Growth Factor-BB and an Injectable Beta-Tricalcium Phosphate/Collagen Matrix. J Orthop Res 2008;26(1):83-90.
15. Wozney JM, Rosen V. Bone Morphogenetic Protein and Bone Morphogenetic Protein Gene Family in Bone Formation and Repair. Clin Orthop Relat Res 1998;(346):26-37.
16. Sakou T. Bone Morphogenetic Proteins: From Basic Studies to Clinical Approaches. Bone 1998;22(6):591-603.
17. Urist, M. R. Bone: Formation by Autoinduction. Science 1965;150:893-9.
18. Hogan, R. L. M. Bone Morphogenetric Proteins: Multifunctional Regulators of Vertebrate Development. Genes & Development 1998;1580-94.
19. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel Regulators of Bone Formation: Molecular Clones and Activities. Science 1988;242:1528-34.
20. Wang EA, Israel DI, Kelly S, Luxenberg DP. Bone Morphogenetic Protein-2 Causes Commitment and Differentiation in C3H10T1/2 and 3T3 Cells. Growth Factors 1993;9(1):57-71.
21. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T. Bone Morphogenetic Protein-2 Converts the Differentiation Pathway of C2C12 Myoblasts into the Osteoblast Lineage. J Cell Biol 1994;127(6Pt1):1755-66.
22. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S. Recombinant Human Bone Morphogenetic Protein-2 Stimulates Osteoblastic Maturation and Inhibits Myogenic Differentiation in Vitro. J Cell Biol 1991;113(3):681-7.
23. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, Zhou L, Luu HH, An N, Breyer B, Vanichakarn P, Szatkowski JP, Park JY, He T. C. Osteogenic Activity of the Fourteen Types of Human Bone Morphogenetic Proteins (BMPs). J Bone Joint Surg Am 2003;85-A(8):1544-5224.
24. Bouxsein ML, Turek TJ, Blake CA, D'Augusta D, Li X, Stevens M, Seeherman HJ, Wozney JM. Recombinant Human Bone Morphogenetic Protein-2 Accelerates Healing in a Rabbit Ulnar Osteotomy Model. Journal of Bone and Joint Surgery 2001;83-A(8):1219-30.
25. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The Healing of Segmental Bone Defects, Induced by Recombinant Human Bone Morphogenetic Protein (rhBMP-2). A Radiographic, Histological, and Biomechanical Study in Rats. Journal of Bone and Joint Surgery 1992;74-A:659-70.
26. Ohura K, Hamanishi C, Tanaka S, Matsuda N. Healing of Segmental Bone Defects in Rats Induced by a Beta- TCP-MCPM Cement Combined With rhBMP-2. J Biomed Mater Res 1999;44(2):168-75.
27. Azad V, Breitbart E, Al Zube L, Yeh S, O'Connor JP, Lin SS. rhBMP-2 Enhances the Bone Healing Response in a Diabetic Rat Segmental Defect Model. J Orthop Trauma 2009;23(4):267-76.
28. Sandhu HS, Kanim LE, Kabo JM, Toth JM, Zeegan EN, Liu D, Seeger LL, Dawson EG. Evaluation of rhBMP-2 With an OPLA Carrier in a Canine Posterolateral (Transverse Process) Spinal Fusion Model. Spine 1995; 20(24):2669-82.
29. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der V, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: a Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients. J Bone Joint Surg Am 2002;84-A(12):2123-34.
30. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, Deyrup AT, Jiang W, Luu HH, Luo J, Szatkowski JP, Vanichakarn P, Park JY, Li Y, Haydon RC, He T-C. Characterization of the Distinct Orthotopic Bone-Forming Activity of 14 BMPs Using Recombinant Adenovirus-Mediated Gene Delivery. Gene Therapy 2004;11:1312-20.
31. Boden SD, Kang J, Sandhu H, Heller JG. Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: a Prospective, Randomized Clinical Pilot Trial: 2002 Volvo Award in Clinical Studies. Spine 2002;27(23):2662-73.
32. Lee SC, Shea M, Battle MA, Kozitza K, Ron E, Turek T, Schaub RG, and Hayes, W. C. Healing of Large Segmental Defects in Rat Femurs Is Aided by rhBMP-2 in PLGA Matrix. Journal of Biomedical Materials Research 1994; 28:1149-56.
33. Lane JM, Yasko AW, Tomin E, Cole BJ, Waller S, Browne M, Turek T, Gross J. Bone Marrow and Recombinant Human Bone Morphogenetic Protein-2 in Osseous Repair. Clin Orthop Relat Res 1999;(361):216-27.
34. Vaidya R, Carp J, Sethi A, Bartol S, Craig J, Les CM. Complications of Anterior Cervical Discectomy and Fusion Using Recombinant Human Bone Morphogenetic Protein-2. Eur Spine J 2007;16(8):1257-65.
35. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB. Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion. Spine (Phila Pa 1976) 2006;31(5):542-7.
36. Rihn JA, Gates C, Glassman SD, Phillips FM, Schwender JD, Albert TJ. The Use of Bone Morphogenetic Protein in Lumbar Spine Surgery. J Bone Joint Surg Am 2008;90(9):2014-25.
37. Wijdicks CA, Virdi AS, Sena K, Sumner DR, Leven RM. Ultrasound Enhances Recombinant Human BMP-2 Induced Ectopic Bone Formation in a Rat Model. Ultrasound Med Biol 7-24-2009;35(10):1629-37.
38. Sarban S, Senkoylu A, Isikan UE, Korkusuz P, Korkusuz F. Can rhBMP-2 Containing Collagen Sponges Enhance Bone Repair in Ovariectomized Rats?: a Preliminary Study. Clin Orthop Relat Res 2009;467(12):3113-20.
39. Sena K, Sumner DR, Virdi AS. Effect of Recombinant Human Transforming Growth Factor-Beta2 Dose on Bone Formation in Rat Femur Titanium Implant Model. J Biomed Mater Res A 2010;92(3):1210-7.
40. Broderick E, Infanger S, Turner TM, Sumner DR. Depressed Bone Mineralization Following High Dose TGFBeta1 Application in an Orthopedic Implant Model. Calcified Tissue International 2005;76(5):379-84.
41. Boyce AS, Reveal G, Scheid DK, Kaehr DM, Maar D, Watts M, Stone MB. Canine Investigation of rhBMP-2, Autogenous Bone Graft, and rhBMP-2 With Autogenous Bone Graft for the Healing of a Large Segmental Tibial Defect. J Orthop Trauma 2009;23(10):685-92.
42. Jones CB, Sabatino CT, Badura JM, Sietsema DL, Marotta JS. Improved Healing Efficacy in Canine Ulnar Segmental Defects With Increasing Recombinant Human Bone Morphogenetic Protein-2/Allograft Ratios. J Orthop Trauma 2008;22(8):550-9.
43. Sciadini MF, Johnson KD. Evaluation of Recombinant Human Bone Morphogenetic Protein-2 As a Bone-Graft Substitute in a Canine Segmental Defect Model. J Orthop Res 2000;18(2):289-302.
44. Reddi AH. Bone Morphogenetic Proteins: From Basic Science to Clinical Applications. J Bone Joint Surg Am 2001;83-A Suppl 1(Pt 1):S1-S6.
45. Geiger M, Li RH, Friess W. Collagen Sponges for Bone Regeneration With rhBMP-2. Adv Drug Deliv Rev 2003; 55(12):1613-29.
46. Currey JD. The Relationship Between the Stiffness and the Mineral Content of Bone. J Biomech 1969;2(4):477-80.
47. Burr DB. The Contribution of the Organic Matrix to Bone's Material Properties. Bone 2002;31(1):8-11.
48. Kloen P, Doty SB, Gordon E, Rubel IF, Goumans MJ, Helfet DL. Expression and Activation of the BMP-Signaling Components in Human Fracture Nonunions. J Bone Joint Surg Am 2002;84-A(11):1909-18.
49. Reed AA, Joyner CJ, Brownlow HC, Simpson AH. Human Atrophic Fracture Non-Unions Are Not Avascular. J Orthop Res 2002;20(3):593-9.
50. Knox JB, Dai JM III, Orchowski J. Osteolysis in Transforaminal Lumbar Interbody Fusion With Bone Morphogenetic Protein-2. Spine (Phila Pa 1976) 2011;36(8):672-6.
51. Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM. Locally Delivered rhBMP-2 Enhances Bone Ingrowth and Gap Healing in a Canine Model. J Orthop Res 2004;22(1):58-65.
52. Toth JM, Boden SD, Burkus JK, Badura JM, Peckham SM, McKay WF. Short-Term Osteoclastic Activity Induced by Locally High Concentrations of Recombinant Human Bone Morphogenetic Protein-2 in a Cancellous Bone Environment. Spine (Phila Pa 1976) 2009;34(6):539-50.
53. Fujimura K, Bessho K, Okubo Y, Kusumoto K, Segami N, Iizuka T. The Effect of Fibroblast Growth Factor-2 on the Osteoinductive Activity of Recombinant Human Bone Morphogenetic Protein-2 in Rat Muscle. Arch Oral Biol 2002;47(8):577-84.
54. Zellin G, Linde A. Effects of Recombinant Human Fibroblast Growth Factor-2 on Osteogenic Cell Populations During Orthopic Osteogenesis in Vivo. Bone 2000;26(2):161-8.
55. Centrella M, McCarthy TL, Canalis E. Transforming Growth Factor β Is a Bifunctional Regulator of Replication and Collagen Synthesis in Osteoblast-Enriched Cell Cultures From Fetal Rat Bone. J Biol Chem 1987; 262(6):2869-74.
56. Schilephake H. Bone Growth Factors in Maxillofacial Skeletal Reconstruction. International Journal of Oral & Maxillofacial Surgery 2002;31(5):469-84.
57. Bostrom M, Lane JM, Tomin E, Browne M, Berberian W, Turek T, Smith J, Wozney J, Schildhauer T. Use of Bone Morphogenetic Protein-2 in the Rabbit Ulnar Nonunion Model. Clin Orthop Relat Res 1996;327:272-82.
58. Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K. Stimulatory Effect of Bone Morphogentic Protein-2 on Osteoclast-Like Cell Formation and Bone-Resorbing Activity. J Bone Miner Res 1995;10(11).
59. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Yabe Y, Kumegawa M, Hakeda Y. Direct Stimulation of Osteoclastic Bone Resorption by Bone Morphogenetic Protein (BMP)-2 and Expression of BMP Receptors in Mature Osteoclasts. Bone 2000; 27(4):479-86.
60. Koide M, Murase Y, Yamato K, Noguchi T, Okahashi N, Nishihara T. Bone Morphogenetic Protein-2 Enhances Osteoclast Formation Mediated by Interleukin-1alpha Through Upregulation of Osteoclast Differentiation Factor and Cyclooxygenase-2. Biochem Biophys Res Commun 1999;259(1):97-102.
61. Einhorn TA. The Cell and Molecular Biology of Fracture Healing. Clinical Orthopaedics & Related Research 1998;(355Suppl):S7-21.
62. Hebel R, Stromberg MW. Myology. Anatomy of the Laboratory Rat.Williams & Wilkins, Baltimore; 1976.